Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
Molecular Therapy - United States
doi 10.1016/j.ymthe.2018.11.003
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2019
Authors
Publisher
Elsevier BV